In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma.

Abstract

BACKGROUND/AIM Multiple myeloma is still an incurable hematological malignancy of monoclonal B-lymphocytes. While standard chemotherapy regimens have been used for years, novel agents like lenalidomide and bortezomib have become an essential part of today's therapies and significantly improve therapeutic efficacy. Nevertheless, new therapeutic strategies… (More)

Topics

  • Presentations referencing similar topics